The publication / Sources
What we read, what it establishes and where its usefulness stops.
These four articles contain dated source notes for their latest revision. Earlier register entries below remain a historical record of what was checked at the stated time.
Offer details in these earlier notes may have changed. For the four revised articles, consult the update notes linked above.
Every record carries its own retrieval date. Product and purchase terms sit alongside regulatory guidance and clinical context; historical research keeps its publication date. Public marketing is not an independently verified outcome.
Current strengths, $48/month starting offer, expanded ingredient descriptions and hormone/application cautions. Dedicated visit CTA /go/timeout confirmed from current PDP; provider-source links retain PDP. No individual order, prescription or exact-mixture clinical trial verified.
Checked 2026-09-27Official page and rendered FAQ checked. Its estriol FDA wording conflicts with FDA guidance; the review explains that specific discrepancy.
Checked 2026-09-26Published February 2, 2026. Ingredient and routine descriptions are provider information, not a personal regimen.
Checked 2026-09-26Rendered formula description and compounded-status FAQ. A current standalone cream price was not established.
Checked 2026-09-26Starting membership amount concerns care access. It is not used as an all-inclusive medication price.
Checked 2026-09-26Rendered offer and expanded age-policy FAQ checked. Exact patient-specific formula remains for confirmation; company ratings are not product trial results.
Checked 2026-09-26Offer accessed September 26, 2026: 1% estriol plus peptides, $90 for one advertised three-month bottle supply. Product title is Eye Cream despite the URL. Provider claims are not independent outcomes; bottle volume and full base were not confirmed.
Checked 2026-09-27Dated August 21, 2025; names several ingredients and links the separate eye study. Marketing summaries and earlier face-cream findings are not interchangeable with eye-product results.
Checked 2026-09-26$59 thirty-day medication supply and separate $79 visit; prescription not guaranteed. Exact strength, full base, live scheduling and final checkout unverified; absorption and safety claims attributed.
Checked 2026-09-27Current $36/month with two-month auto-refill display, 17,123 self-report cohort and conditional 60-day refund language. No completed checkout, one-time total or controlled exact-product study established.
Checked 2026-09-27Names Plump estriol 0.3% and hyaluronic acid 0.5%, with individualized-prescription caveat. Routine wording mixes morning and night references; review defers to written prescriber directions.
Checked 2026-09-27Current destination of /go/timeout. Lists twelve-month $576, six-month $330, three-month $189 and one-month $75 totals; some displayed monthly rates differ by cents from total/division arithmetic. No auto-billing and refund if not approved are advertised, not checkout-verified. Testimonials, comparative claims and timelines are not independent trial evidence.
Checked 2026-09-27Official product ingredients, displayed prices and subscription renewal, checked October 4, 2026. No patient care or fulfillment test performed.
Checked 2026-10-04Primary source stating no estriol-containing drugs are FDA-approved. General hormone guidance is not an individual risk estimate.
Checked 2026-09-27Explains compounded-drug approval status and premarket review differences.
Checked 2026-09-27Links to state-board licensing resources. We have not audited each provider’s dispensing pharmacies.
Checked 2026-09-26Intended-use distinctions and the absence of a legal cosmeceutical category. Used for classification principles, not stale regulatory implementation deadlines or a ruling on a particular retail product.
Checked 2026-09-26Specific vaginal estradiol label with ANDA marketing category and systemic-absorption language. It does not establish facial estriol efficacy, comparable exposure or instructions for repurposing either product.
Checked 2026-09-26Official voluntary consumer reporting information for medical-product adverse events, quality problems and related concerns. Reports support surveillance; they do not establish causation, deliver medical care or settle refunds.
Checked 2026-09-26Public source checked for this editorial review; no product-use or transaction test.
Checked 2026-10-14Drug information revised December 15, 2025. Used for retinoid identity and broad precautions, not a dosing schedule for a compounded combination.
Checked 2026-09-26Routine skin care and assessment context. Does not endorse a listed estriol brand.
Checked 2026-09-26November 2023 consensus discusses limited evidence for adjunct testing to prescribe or dose compounded menopausal hormone therapy. Broad MHT guidance is not a validated facial estriol testing algorithm; some clinical circumstances warrant separate testing decisions.
Checked 2026-09-26July 20, 2023 guidance on useful photographs and clinic-approved secure sharing. It does not establish hormone eligibility from an image or verify any provider’s upload process.
Checked 2026-09-26August 18, 2023 guidance on visit preparation, medical history and follow-up. Remote assessment may lead to in-person care.
Checked 2026-09-26Public source checked for this editorial review; no product-use or transaction test.
Checked 2026-10-14Abstract reviewed: 59 women and six months. Historical ingredient research, not a trial of these current commercial formulas.
Checked 2026-09-26Alloy-sponsored monadic report: 40 enrolled, 34 completed, no comparator described, 12-week outcomes and baseline/week-eight estriol sampling. Pages 14 and 18 and the laboratory appendix were checked directly: probable bilateral eye burning was recorded; laboratory uncertainty limits absorption interpretations. Small selected population and short follow-up cannot establish universal or long-term safety.
Checked 2026-09-26Original 2026 conference abstract P-124 and its complete table, PDF page50; text and rendered page reviewed
Checked 2026-10-21Primary full article: methods, main results, participant table, figure captions, discussion and funding reviewed on publisher site
Checked 2026-10-21Indexed primary study abstract
Checked 2026-10-21Updated August 6, 2025. Symptoms, assessment and treatment categories; not evidence for facial estriol or a personal eye-drop regimen.
Checked 2026-09-27Updated December 6, 2024. Age, hormonal context and other causes. A risk factor is not an individual diagnosis.
Checked 2026-09-27July 2019 document; model-specific approximate volumes and prescription-label instructions. Not a personal dose, current-device audit or evidence that any reviewed brand uses this dispenser.
Checked 2026-09-27Individualized preparation and approval distinctions; not a conversion table or validation of a particular pharmacy/device.
Checked 2026-09-27Lot matching, risk categories and notice-specific action; not every recall has a public announcement. General guidance is not a patient-specific continuation decision.
Checked 2026-09-27Official announcement index and recall explanation. No complete recall-history audit or claim that any listed estriol product is currently recalled.
Checked 2026-09-27Homepage shipping reference; customer service and payment details supplied for this review, without a checkout or timed support test
Checked 2026-10-12Public source checked for this editorial review; no product-use or transaction test.
Checked 2026-10-14Public source checked for this editorial review; no product-use or transaction test.
Checked 2026-10-14Public source checked for this editorial review; no product-use or transaction test.
Checked 2026-10-14Public source checked for this editorial review; no product-use or transaction test.
Checked 2026-10-14Public source checked for this editorial review; no product-use or transaction test.
Checked 2026-10-14Public source checked for this editorial review; no product-use or transaction test.
Checked 2026-10-14Public source checked for this editorial review; no product-use or transaction test.
Checked 2026-10-14Public source checked for this editorial review; no product-use or transaction test.
Checked 2026-10-14Public source checked for this editorial review; no product-use or transaction test.
Checked 2026-10-14